News|Articles|October 2, 2004
- Pharmaceutical Technology-10-02-2004
- Volume 28
- Issue 10
Drug Development Linked More Closely to Diagnostics
Author(s)Jill Wechsler
FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.
Advertisement
Articles in this issue
almost 22 years ago
A Novel Freeze Pelletization Technique for Preparing Matix Pelletsalmost 22 years ago
Aseptic Processing: A Review of Current Industry Practicealmost 22 years ago
Can Inserts Be Improved?almost 22 years ago
In The Spotlight-October 2004almost 22 years ago
October 2004almost 22 years ago
The High Price of Successalmost 22 years ago
Pharma Company Investment in Parenteral Manufacturing Capacity Picking UpAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization
2
The FDA Gives Accelerated Approval to Melanoma Treatment
3
Why the Orzeyful Approval Matters Beyond One Drug Class
4
What Does Moderna's mRNA Flu Vaccine Approval Signal?
5